The US Food and Drug Administration approved Isemblyd for the treatment of spinal muscular atrophy in patients 2 years and older.

Zhitongcaijing · 1d ago
The US Food and Drug Administration approved Isemblyd for the treatment of spinal muscular atrophy in patients 2 years and older.